Viewing Study NCT02227459

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 2:45 PM
Ignite Modification Date: 2026-02-21 @ 11:35 PM
Study NCT ID: NCT02227459
Status: COMPLETED
Last Update Posted: 2017-05-11
First Post: 2014-08-25
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Phase 1b/2, Open Label, Repeat Dose, Dose Escalation Study of ND-L02-s0201 Injection in Subjects With Moderate to Extensive Fibrosis (METAVIR F3-4)
Sponsor: Bristol-Myers Squibb
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Moderate to Extensive Hepatic Fibrosis (METAVIR F3-4) View
Keywords: